Monday, July 02, 2018 2:24:55 AM
I see nothing positive has changed for this bio scam. Ppl are still dreaming about pmcb applying for IND. Dreaming pmcb is a legit biotech. Dreaming of partnering and or buyouts. This scam has now managed to dilute investors with 1,013,260,644 shares outstanding.
Other than that they have done nothing with CIAB in the last 7 years to advance it. Nothing but reel in those who believed in the sales pitch by old Kenny Waggoner.
Kenny boy was paid over $750m in total compensation last year (2017)! Investors should be asking one question. For what?
As an attorney for scam companies in the past I suppose it shouldn’t come as a surprise he struck again.
https://www1.salary.com/Kenneth-L-Waggoner-JD-Salary-Bonus-Stock-Options-for-PHARMACYTE-BIOTECH-INC.html
Other than that they have done nothing with CIAB in the last 7 years to advance it. Nothing but reel in those who believed in the sales pitch by old Kenny Waggoner.
Kenny boy was paid over $750m in total compensation last year (2017)! Investors should be asking one question. For what?
As an attorney for scam companies in the past I suppose it shouldn’t come as a surprise he struck again.
https://www1.salary.com/Kenneth-L-Waggoner-JD-Salary-Bonus-Stock-Options-for-PHARMACYTE-BIOTECH-INC.html
Disclosure: I am involved in and support the SEC whistleblower program, I may be rewarded cash for information that leads to the successful enforcement by the SEC of a federal court or administrative action of 1m+.
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
